Motor hal dengesindeki kayma, deneysel Parkinsonizmde apomorfin'in yürüyüş terapisi etkilerini açıklıyor
Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism
DOI: 10.1101/2025.09.07.673890
Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism
DOI: 10.1101/2025.09.07.673890
Oxidative genomic or genotoxic stress in neurodegeneration: Mechanisms and therapeutic avenues.
DOI: 10.3934/neuroscience.2025020PMID: 41103972
Deep learning-powered temperature prediction for optimizing transcranial MR-guided focused ultrasound treatment.
DOI: 10.3171/2025.5.jns25291PMID: 40939202
The Cost-Effectiveness of Opicapone Versus Entacapone as Adjuvant Therapy for Levodopa-Treated Individuals With Parkinson's Disease Experiencing End-of-Dose Motor Fluctuations.
DOI: 10.1155/padi/8408907PMID: 40979212
<i>Akkermansia muciniphila</i> in neurological disorders: mechanisms and therapeutic potential via the gut-brain axis.
DOI: 10.3389/fnins.2025.1650807PMID: 41017972
Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder.
DOI: 10.3389/fgene.2025.1590292PMID: 41019763
Correction to: Photobiomodulation Therapy and Cell Therapy Improved Parkinson's Diseases by Neuro-regeneration and Tremor Inhibition.
DOI: 10.34172/jlms.2025.34PMID: 41255722
The Landscape of Parkinson's Disease Treatment in India: A National Cross-Sectional Survey of Clinical Practitioners.
DOI: 10.14802/jmd.25201PMID: 40931469
Bilateral Putaminal Convection of Adeno-Associated Virus Vector Serotype 2 Glial Cell Line-Derived Neurotrophic Factor Gene Therapy in Parkinson's Disease May Provide Glial Cell Line-Derived Neurotrophic Factor Transgene Expression to Caudate Nucleus: Potential Role of Perivascular and Other Low Resistance Leakage Pathways.
DOI: 10.1227/neu.0000000000003729PMID: 40932279
Natural Products from Chinese Medicine Targeting NF-κB Signaling: Emerging Therapeutic Avenues for Neurodegenerative Diseases.
DOI: 10.2147/dddt.s534706PMID: 40955309
Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaption.
DOI: 10.3389/fnagi.2025.1619850PMID: 41001152
Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.
DOI: 10.1007/s11064-025-04543-3PMID: 40928730
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.